Chasov V - Search Results

1

Immunotherapy Strategy for Systemic Autoimmune Diseases: Betting on CAR-T Cells and Antibodies.

Chasov V, Zmievskaya E, Ganeeva I, Gilyazova E, Davletshin D, Khaliulin M, Kabwe E, Davidyuk YN, Valiullina A, Rizvanov A, Bulatov E. Chasov V, et al. Antibodies (Basel). 2024 Feb 1;13(1):10. doi: 10.3390/antib13010010. Antibodies (Basel). 2024. PMID: 38390871 Free PMC article. Review.

2

USP7 Inhibitors in Cancer Immunotherapy: Current Status and Perspective.

Korenev G, Yakukhnov S, Druk A, Golovina A, Chasov V, Mirgayazova R, Ivanov R, Bulatov E. Korenev G, et al. Among authors: chasov v. Cancers (Basel). 2022 Nov 10;14(22):5539. doi: 10.3390/cancers14225539. Cancers (Basel). 2022. PMID: 36428632 Free PMC article. Review.

3

Assessment of Thermal Stability of Mutant p53 Proteins via Differential Scanning Fluorimetry.

Khadiullina R, Mirgayazova R, Davletshin D, Khusainova E, Chasov V, Bulatov E. Khadiullina R, et al. Among authors: chasov v. Life (Basel). 2022 Dec 22;13(1):31. doi: 10.3390/life13010031. Life (Basel). 2022. PMID: 36675980 Free PMC article.

4

Asymmetric T-cell division: insights from cutting-edge experimental techniques and implications for immunotherapy.

Kaminskiy Y, Ganeeva I, Chasov V, Kudriaeva A, Bulatov E. Kaminskiy Y, et al. Among authors: chasov v. Front Immunol. 2024 Mar 1;15:1301378. doi: 10.3389/fimmu.2024.1301378. eCollection 2024. Front Immunol. 2024. PMID: 38495874 Free PMC article. Review.

5

Anticancer therapeutic strategies for targeting mutant p53-Y220C.

Chasov V, Davletshin D, Gilyazova E, Mirgayazova R, Kudriaeva A, Khadiullina R, Yuan Y, Bulatov E. Chasov V, et al. J Biomed Res. 2023 Nov 28:222-232. doi: 10.7555/JBR.37.20230093. Online ahead of print. J Biomed Res. 2023. PMID: 38738269 Free article.

6

Evaluation of GHK peptide-heparin interactions in multifunctional liposomal covering.

Nikolaeva V, Kamalov M, Abdullin TI, Salakhieva D, Chasov V, Rogov A, Zoughaib M. Nikolaeva V, et al. Among authors: chasov v. J Liposome Res. 2024 Mar;34(1):18-30. doi: 10.1080/08982104.2023.2206894. Epub 2023 May 5. J Liposome Res. 2024. PMID: 37144381

7

Promising New Tools for Targeting p53 Mutant Cancers: Humoral and Cell-Based Immunotherapies.

Chasov V, Zaripov M, Mirgayazova R, Khadiullina R, Zmievskaya E, Ganeeva I, Valiullina A, Rizvanov A, Bulatov E. Chasov V, et al. Front Immunol. 2021 Aug 13;12:707734. doi: 10.3389/fimmu.2021.707734. eCollection 2021. Front Immunol. 2021. PMID: 34484205 Free PMC article. Review.

8

Key Players in the Mutant p53 Team: Small Molecules, Gene Editing, Immunotherapy.

Chasov V, Mirgayazova R, Zmievskaya E, Khadiullina R, Valiullina A, Stephenson Clarke J, Rizvanov A, Baud MGJ, Bulatov E. Chasov V, et al. Front Oncol. 2020 Aug 18;10:1460. doi: 10.3389/fonc.2020.01460. eCollection 2020. Front Oncol. 2020. PMID: 32974171 Free PMC article. Review.

9

Therapeutic Editing of the TP53 Gene: Is CRISPR/Cas9 an Option?

Mirgayazova R, Khadiullina R, Chasov V, Mingaleeva R, Miftakhova R, Rizvanov A, Bulatov E. Mirgayazova R, et al. Among authors: chasov v. Genes (Basel). 2020 Jun 25;11(6):704. doi: 10.3390/genes11060704. Genes (Basel). 2020. PMID: 32630614 Free PMC article. Review.

10

N- and C-terminal regions of the small heat shock protein IbpA from Acholeplasma laidlawii competitively govern its oligomerization pattern and chaperone-like activity.

Chernova LS, Bogachev MI, Chasov VV, Vishnyakov IE, Kayumov AR. Chernova LS, et al. Among authors: chasov vv. RSC Adv. 2020 Feb 26;10(14):8364-8376. doi: 10.1039/c9ra10172a. eCollection 2020 Feb 24. RSC Adv. 2020. PMID: 35497866 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page